RÉSUMÉ
Ectopic parathyroid adenomas are an uncommon etiology of primary hyperparathyroidism. We present a case of a patient admitted to the hospital with severe hypercalcemia and elevated parathyroid hormone levels, in whom imaging revealed two distinct parathyroid masses in the prevertebral space, representing a rare and atypical location for parathyroid tissue. This case highlights the importance of considering ectopic parathyroid adenomas as a potential cause of hyperparathyroidism and discusses the diagnostic challenges and management strategies associated with such cases.
Sujet(s)
Adénomes , Tumeurs de la parathyroïde , Humains , Tumeurs de la parathyroïde/chirurgie , Tumeurs de la parathyroïde/complications , Tumeurs de la parathyroïde/diagnostic , Adénomes/chirurgie , Adénomes/complications , Adénomes/anatomopathologie , Choristome/complications , Choristome/chirurgie , Choristome/diagnostic , Femelle , Hyperparathyroïdie primitive/étiologie , Hyperparathyroïdie primitive/chirurgie , Hyperparathyroïdie primitive/diagnostic , Hyperparathyroïdie primitive/complications , Adulte d'âge moyen , Mâle , Glandes parathyroïdes/imagerie diagnostique , Glandes parathyroïdes/anatomopathologie , Parathyroïdectomie , Hypercalcémie/étiologieRÉSUMÉ
Background: Well-annotated, high-quality biorepositories provide a valuable platform to support translational research. However, most biorepositories have poor representation of minority groups, limiting the ability to address health disparities. Methods: We describe the establishment of the Florida Pancreas Collaborative (FPC), the first state-wide prospective cohort study and biorepository designed to address the higher burden of pancreatic cancer (PaCa) in African Americans (AA) compared to Non-Hispanic Whites (NHW) and Hispanic/Latinx (H/L). We provide an overview of stakeholders; study eligibility and design; recruitment strategies; standard operating procedures to collect, process, store, and transfer biospecimens, medical images, and data; our cloud-based data management platform; and progress regarding recruitment and biobanking. Results: The FPC consists of multidisciplinary teams from fifteen Florida medical institutions. From March 2019 through August 2020, 350 patients were assessed for eligibility, 323 met inclusion/exclusion criteria, and 305 (94%) enrolled, including 228 NHW, 30 AA, and 47 H/L, with 94%, 100%, and 94% participation rates, respectively. A high percentage of participants have donated blood (87%), pancreatic tumor tissue (41%), computed tomography scans (76%), and questionnaires (62%). Conclusions: This biorepository addresses a critical gap in PaCa research and has potential to advance translational studies intended to minimize disparities and reduce PaCa-related morbidity and mortality.
